Morgan Stanley lowered its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst PT Change

Momenta Phama (MNTA) Says '17 Approval Possible for its Copaxone Generic - Bloomberg, Citing EmailOctober 4, 2017 3:53 PM Teva Pharma (TEVA) PT Lowered to $21 at Barclays; Generic Copaxone 40mg Approval 'Will Offset Some Contracting Strategies... Hurt Sentiment'October 4, 2017 12:17 PM Teva Pharma (TEVA) volatility increases on Mylan (MYL) granted FDA approval of CopaxoneOctober 4, 2017 12:02 PM Momenta Phama (MNTA) Declines to Comment on Status of Generic Capoxone 40mg - BloombergOctober 4, 2017 9:53 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Oct 04October 4, 2017 9:53 AM Pre-Open Stock Movers 10/04: (CTMX) (CATB) (MYL) Higher; (CLSN) (MNTA) (TEVA) (ODP) Lower (more...)October 4, 2017 9:30 AM Teva Pharma (TEVA): Downside From $16 Likely, Cutting PT - CowenOctober 4, 2017 9:28 AM Teva Pharma (TEVA) Says it Remains Confident in Patient and Physician Loyalty to COPAXONEOctober 4, 2017 9:28 AM Teva Comments on Anticipated At-Risk U.S. Launch of Generic Glatiramer Acetate 40mg/mL and Launch of Generic Glatiramer Acetate 20mg/mLOctober 4, 2017 9:26 AM Wall St. extends run of record highs; services data upbeatOctober 4, 2017 7:54 AM Mylan (MYL) PT Raised to $45 at BTIG Following Copaxone Generic ApprovalOctober 4, 2017 7:27 AM Mylan's (MYL) Surprise Copaxone Generic Approval 'Quite Negative' for Teva Pharma (TEVA) - MizuhoOctober 4, 2017 7:02 AM Momenta Phama (MNTA) on Watch After Mylan (MYL) Granted FDA Approval of First Generic for CopaxoneOctober 4, 2017 6:42 AM Teva Pharma (TEVA) volatility flat into Mylan (MYL) granted FDA approval of CopaxoneOctober 4, 2017 6:20 AM Teva (TEVA) Shares Pressured After Mylan (MYL) Granted FDA Approval of First Generic for CopaxoneOctober 4, 2017 6:14 AM